Today: 9 June 2026
ASX slides as Trump Greenland tariff threat sparks ‘sell America’ trade — gold hits record
21 January 2026
2 mins read

ASX slides as Trump Greenland tariff threat sparks ‘sell America’ trade — gold hits record

SYDNEY, Jan 21, 2026, 11:00 (AEDT)

  • Australia’s ASX 200 dips at the open, while miners gain ground on soaring bullion prices
  • Trump warns of fresh tariffs targeting eight European nations amid Greenland spat
  • Lynas surges as prices climb; Rio Tinto and BHP deliver robust iron ore production numbers

Australian shares slipped on Wednesday, though the drop was milder than futures had predicted as miners benefited from a record gold price. By 10:30 a.m. AEDT, the S&P/ASX 200 was down 0.4% at 8,779. Tech, banks, and industrials lagged, while materials and energy sectors gained ground. Spot gold hovered near $4,762 an ounce, Brent crude around $64 a barrel, and the Australian dollar stayed close to 67.3 U.S. cents.

The selloff followed a global slide, with the S&P 500 dropping roughly 2% overnight and Europe’s STOXX 600 down 0.7%, as investors reacted to new trade threats from U.S. President Donald Trump. “The geopolitical risks … are re-emerging and are shifting market perceptions of common alliances across allies in Europe,” said Wasif Latif, chief investment officer at Sarmaya Partners. Strategists are bringing back the term “sell America,” a quick way to describe reducing holdings in U.S. stocks and the dollar amid rising policy risks. Reuters

Trump has threatened to impose new tariffs on imports from Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland, and Britain after these countries deployed small military contingents to Greenland at Copenhagen’s request. The tariffs would kick in at 10% starting Feb. 1, then jump to 25% on June 1, and remain until the U.S. secures a deal to buy Greenland, according to Sweden’s Board of Trade.

European shares hit their lowest level in almost two weeks before closing 0.7% down on Tuesday, with Germany’s DAX falling 1%. Deutsche Bank analysts, led by Jim Reid, said markets have priced in some reaction but there’s potential for bigger swings if the rhetoric heats up, especially with Trump set to speak at the World Economic Forum in Davos.

Some investors remain skeptical the White House will act, and a shift to a softer stance could quickly soothe markets. “Geopolitical tensions have dented sentiment and cooled early-year exuberance, but they haven’t fundamentally altered the global growth or earnings outlook,” said Laura Cooper, senior macro strategist at Nuveen. Reuters

In Australia, the risk-off sentiment was clear in the sector split: defensive stocks fared better, while growth names took another hit.

Lynas Rare Earths surged following a 43% jump in second-quarter revenue to A$201.9 million. The boost came from higher prices, which made up for reduced output after power issues at its Kalgoorlie plant in Western Australia. Rare earths are metals essential for electric vehicles, smartphones, and some defense systems.

Rio Tinto posted record iron ore shipments for the fourth quarter from its Pilbara mines, moving 91.3 million tonnes and surpassing analyst expectations. The miner also saw a rise in copper production, driven by its Oyu Tolgoi ramp-up, positioning it ahead of rival Vale. Meanwhile, Rio Tinto is engaged in early takeover discussions with Glencore.

Peer BHP reported a record 146.6 million tonnes of iron ore output in the first half from Western Australia. However, it acknowledged accepting lower prices on some sales amid talks for a 2026 supply deal with China’s state buyer. RBC Capital Markets analyst Kaan Peker noted that restrictions on Chinese purchasing could tighten spot market supply and bolster the benchmark price, despite BHP facing steeper discounts.

On the ASX, the looming question is straightforward: will tariff threats become reality, and what will Europe do next? Traders say until that’s settled, safe-haven buying and volatile intraday moves are likely to persist.

Stock Market Today

  • Docebo (TSX:DCBO) Valuation Story Shifts Amid Revised Earnings Guidance
    June 9, 2026, 10:40 AM EDT. Docebo's fair value remains at CA$35.97 despite updated financial models, reflecting a recalibration of valuation assumptions. Analysts highlight contrasting bullish views, citing a clear growth story backed by recent revenue guidance raising full-year 2026 estimates to US$271-275 million, against bearish concerns over limited analyst coverage and potential risks. The e-learning software provider forecast revenue of approximately US$65.4-65.6 million for Q1 2026, and US$66.7-66.9 million for Q2. At its Inspire 2026 event, Docebo unveiled a next-generation learning platform and key product updates, signaling strategic progress. Investors should monitor shifting assumptions and sector context amid evolving market narratives.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps
Previous Story

Dow Jones today: Dow drops 870 points on Trump Greenland tariff threat as volatility jumps

BAE Systems share price: fresh buyback filing hits tape before London open
Next Story

BAE Systems share price: fresh buyback filing hits tape before London open

Go toTop